Is cefixime (Cefixime) 400 mg/day an appropriate treatment for pyelonephritis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Cefixime 400 mg/day for Pyelonephritis Treatment

Cefixime 400 mg/day is not recommended as monotherapy for pyelonephritis, but can be used as part of a sequential therapy following initial parenteral treatment with a long-acting antimicrobial such as ceftriaxone. 1

Recommended Treatment Approach for Pyelonephritis

First-line Treatment Options

  • Fluoroquinolones are the preferred oral agents for uncomplicated pyelonephritis in areas with low resistance rates (<10%), typically given for 7 days 1
  • Ciprofloxacin 500 mg twice daily for 7 days is the most well-studied oral regimen 1
  • Once-daily fluoroquinolones (ciprofloxacin 1000 mg extended-release for 7 days or levofloxacin 750 mg for 5 days) are also effective options 1

When to Use Cefixime

  • Oral β-lactams, including cefixime, are considered less effective than fluoroquinolones for pyelonephritis 1
  • If using cefixime or other oral β-lactams, an initial intravenous dose of a long-acting parenteral antimicrobial is strongly recommended 1
  • The recommended approach is:
    • Initial dose of ceftriaxone 1g IV 1
    • Followed by oral cefixime 400 mg daily 2
    • Total treatment duration of 10-14 days for β-lactam regimens 1

Evidence for Cefixime in Pyelonephritis

  • A 2016 pilot study showed promising results with 1g ceftriaxone followed by cefixime 400 mg/day for 6 days in women with acute pyelonephritis, with negative urine cultures in all patients by day 9 2
  • Another study demonstrated that initial therapy with IV ceftriaxone (1g) followed by oral cefixime (400 mg once daily for 2 days) was comparable to 3 days of IV ceftriaxone, with both groups then completing a 10-day course based on susceptibility results 1
  • A 2002 study found that a single IV dose of ceftriaxone followed by oral cefixime was effective for initial treatment of acute uncomplicated pyelonephritis in women 3

Important Considerations

Urine Culture and Susceptibility Testing

  • Always perform urine culture and susceptibility testing before initiating therapy for pyelonephritis 1
  • Tailor therapy based on susceptibility results when available 1

Local Resistance Patterns

  • Consider local resistance patterns when selecting empiric therapy 1
  • In areas with fluoroquinolone resistance >10%, initial parenteral therapy becomes more important 1

Duration of Therapy

  • For β-lactam regimens including cefixime, maintain the traditional 10-14 day treatment duration 1
  • This is longer than the 5-7 day regimens that have been validated for fluoroquinolones 1

Common Pitfalls to Avoid

  • Using cefixime as monotherapy without an initial parenteral dose in pyelonephritis 1
  • Failing to obtain urine culture before initiating antibiotics 1
  • Not considering local resistance patterns when selecting empiric therapy 1
  • Using shorter treatment durations with β-lactams than the recommended 10-14 days 1

In summary, while cefixime 400 mg/day can be part of a treatment regimen for pyelonephritis, it should follow an initial dose of a long-acting parenteral antimicrobial such as ceftriaxone, and the total treatment duration should be 10-14 days.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.